1. The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcoma. Issue 3 (4th March 2019) Authors: Ghayad, Sandra E.; Rammal, Ghina; Sarkis, Omar; Basma, Hussein; Ghamloush, Farah; Fahs, Assil; Karam, Mia; Harajli, Mohamad; Rabeh, Wissam; Mouawad, Joe E.; Zalzali, Hassan; Saab, Raya Journal: Cancer biology & therapy Issue: Volume 20:Issue 3(2019) Page Start: 272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗